BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11535532)

  • 1. The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal.
    Migone TS; Humbert M; Rascle A; Sanden D; D'Andrea A; Johnston JA
    Blood; 2001 Sep; 98(6):1935-41. PubMed ID: 11535532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors.
    Callus BA; Mathey-Prevot B
    Blood; 1998 May; 91(9):3182-92. PubMed ID: 9558373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
    Cheng J; Zhang D; Zhou C; Marasco WA
    Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
    Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    Carlesso N; Frank DA; Griffin JD
    J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2 is required for induction of the murine DUB-1 gene.
    Jaster R; Zhu Y; Pless M; Bhattacharya S; Mathey-Prevot B; D'Andrea AD
    Mol Cell Biol; 1997 Jun; 17(6):3364-72. PubMed ID: 9154835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.
    Migone TS; Lin JX; Cereseto A; Mulloy JC; O'Shea JJ; Franchini G; Leonard WJ
    Science; 1995 Jul; 269(5220):79-81. PubMed ID: 7604283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation.
    Yu CL; Burakoff SJ
    J Biol Chem; 1997 May; 272(22):14017-20. PubMed ID: 9162019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.
    Takemoto S; Mulloy JC; Cereseto A; Migone TS; Patel BK; Matsuoka M; Yamaguchi K; Takatsuki K; Kamihira S; White JD; Leonard WJ; Waldmann T; Franchini G
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13897-902. PubMed ID: 9391124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
    Chida D; Wakao H; Yoshimura A; Miyajima A
    Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.
    Matsumoto A; Seki Y; Kubo M; Ohtsuka S; Suzuki A; Hayashi I; Tsuji K; Nakahata T; Okabe M; Yamada S; Yoshimura A
    Mol Cell Biol; 1999 Sep; 19(9):6396-407. PubMed ID: 10454585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
    Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
    Bright JJ; Kerr LD; Sriram S
    J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein.
    Verdier F; Chrétien S; Muller O; Varlet P; Yoshimura A; Gisselbrecht S; Lacombe C; Mayeux P
    J Biol Chem; 1998 Oct; 273(43):28185-90. PubMed ID: 9774439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.
    Matsumoto A; Masuhara M; Mitsui K; Yokouchi M; Ohtsubo M; Misawa H; Miyajima A; Yoshimura A
    Blood; 1997 May; 89(9):3148-54. PubMed ID: 9129017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
    Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
    Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
    Castro A; Sengupta TK; Ruiz DC; Yang E; Ivashkiv LB
    J Immunol; 1999 Feb; 162(3):1261-9. PubMed ID: 9973378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells.
    Sun SC; Maggirwar SB; Harhaj EW; Uhlik M
    Oncogene; 1999 Feb; 18(7):1401-9. PubMed ID: 10050877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.